Vol. 28 No. 4 (2018): Edição Especial (V CESMEV)
Resumo Expandido - Relatos de Caso

Cutaneous adverse drug reaction after topical administration of Mupirocin in dog

Tiago Cunha FERREIRA
Programa de Pós-Graduação em Ciências Veterinárias (PPGCV)
Alexandre Tavares Camelo OLIVEIRA
Programa de Pós-Graduação em Ciências Veterinárias (PPGCV)
Rodrigo Fonseca de Medeiros GUEDES
2Faculdade de Veterinária – INTA/Sobral
Belise Maria Oliveira BEZERRA
Programa de Pós-Graduação em Ciências Veterinárias (PPGCV)
Diana Célia Sousa Nunes PINHEIRO
Programa de Pós-Graduação em Ciências Veterinárias (PPGCV)

Published 2023-04-20

Keywords

  • Cutaneous Adverse Drug Reaction,
  • dog,
  • mupirocin,
  • allergic reaction

How to Cite

FERREIRA, T. C.; OLIVEIRA, A. T. C.; GUEDES, R. F. de M.; BEZERRA, B. M. O.; PINHEIRO, D. C. S. N. Cutaneous adverse drug reaction after topical administration of Mupirocin in dog. Ciência Animal, [S. l.], v. 28, n. 4, p. 38–40, 2023. Disponível em: https://revistas.uece.br/index.php/cienciaanimal/article/view/10461. Acesso em: 30 jan. 2026.

Abstract

Pharmacodermia is defined as adverse reaction in skin, mucosa and appendages, capable of generating morpho-functional alterations in cutaneous barrier. The purpose of this study was to report a cutaneous adverse drug reaction after topical use of mupirocin in dog. The diagnosis was made through clinical-cytological analyzes. The therapy involved topical and systemic immunomodulatory drugs. Therefore, it is concluded that Mupirocin is capable of generating pharmacodermic reactions.

Downloads

Download data is not yet available.

References

  1. FUCHS, P.C.; JONES, R.N.; BARRY, A.L. Interpretive criteria for disk diffusion susceptibilitytesting of mupirocin, a topical antibiotic. Journal of Clinical Microbiology, v.28, p.608–609, 1990.
  2. HILLIER, A.; LLOYD, D.H.; SCOTT-WEESE, J. Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases). Veterinary Dermatology., n.25, p.163-43, 2014.
  3. KHAN, D.A.; SOLENSKY, R. Drug allergy. Journal of Allergy and Clinical Immunology, n.125, p.126–137, 2010.
  4. LARSSON, C.E. Drug eruption (DE). In: 27 WSAVA 2002, Granada. Disponível em: http://www.vin.com/proceedings/Proceedings.plx?CID=WSAVA2002&PID=2551/.
  5. NARANJO, C.A.; BUSTO, U.; SELLERS, E.M. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics, n.30, p.239–245, 1981.
  6. NAYAK, S.; ACHARJYA, B. Adverse cutaneous drug reaction. Indian Journal of Dermatology, v.53, p.2-8, 2008.
  7. PARK, J.H.; KANG, J.H.; HYUN, J.E. Low prevalence of Mupirocin resistance in Staphylococcus pseudointermedius isolates from canine pyoderma in Korea. Veterinary Dermatology, v.29, p.95-e37, 2018.